Stefan Vitorovic - Jan 6, 2022 Form 3 Insider Report for Vigil Neuroscience, Inc. (VIGL)

Role
Director
Signature
/s/ Jennifer Ziolkowski, Attorney-in-Fact
Stock symbol
VIGL
Transactions as of
Jan 6, 2022
Transactions value $
$0
Form type
3
Date filed
1/6/2022, 07:54 PM
Previous filing
Jun 9, 2021
Next filing
Jan 11, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding VIGL Series B Preferred Stock Jan 6, 2022 Common Stock 3.33M By Vida Ventures III, L.P. F1, F2
holding VIGL Series B Preferred Stock Jan 6, 2022 Common Stock 7.68K By Vida Ventures III-A, L.P. F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares of Series B Preferred Stock are convertible into Common Stock on a one-for-2.7732 basis at the option of the holder, and will automatically convert into the number of shares shown in Column 3 immediately prior to the closing of the Issuer's initial public offering. The Series B Preferred Stock has no expiration date.
F2 The shares are held directly by Vida Ventures III, L.P. ("Vida III"). Vida Ventures GP III, L.L.C. ("Vida III GP") is the general partner of of Vida III. The Reporting Person is a managing member of Vida III GP and disclaims beneficial ownership of the shares held directly by Vida III, except to the extent of his pecuniary interest therein, if any.
F3 The shares are held directly by Vida Ventures III-A, L.P. ("Vida III-A"). Vida III GP is the general partner of of Vida III-A. The Reporting Person is a managing member of Vida III GP and disclaims beneficial ownership of the shares held directly by Vida III-A, except to the extent of his pecuniary interest therein, if any.

Remarks:

Exhibit 24 - Power of Attorney